Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A (FANCOLEN-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03157804
Recruitment Status : Active, not recruiting
First Posted : May 17, 2017
Last Update Posted : November 25, 2020
Sponsor:
Collaborators:
Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)
Centro de Investigación en Red de Enfermedades Raras (CIBERER)
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Hospital Vall d'Hebron
Universitat Autonoma de Barcelona
Information provided by (Responsible Party):
Julian Sevilla, Hospital Infantil Universitario Niño Jesús, Madrid, Spain

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : April 23, 2019
Estimated Study Completion Date : April 2022
Publications of Results:
Other Publications: